472 related articles for article (PubMed ID: 17927860)
41. Integrin expression and survival in human breast cancer.
Berry MG; Gui GP; Wells CA; Carpenter R
Eur J Surg Oncol; 2004 Jun; 30(5):484-9. PubMed ID: 15135474
[TBL] [Abstract][Full Text] [Related]
42. [Cytoplasmic expression of aquaporin-1 in breast cancer cells and its relationship with clinicopathological characteristics and prognosis].
Zhang B; Liu FF; Ma YJ; Gu F
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):904-9. PubMed ID: 24506959
[TBL] [Abstract][Full Text] [Related]
43. Immunohistochemical expression of T, Tn and sialyl-Tn antigens and clinical outcome in human breast carcinoma.
Imai J; Ghazizadeh M; Naito Z; Asano G
Anticancer Res; 2001; 21(2B):1327-34. PubMed ID: 11396208
[TBL] [Abstract][Full Text] [Related]
44. [Expression and clinical significance of cytokeratin 19 in bone marrow of patients with breast cancer].
Li BJ; Huang XP; Wei WD; Wang JY; Su XD; Zhang X; Hong WS; Tang J; Zhang LJ; Long H; Yang MT; Rong TH
Ai Zheng; 2005 Jun; 24(6):735-9. PubMed ID: 15946491
[TBL] [Abstract][Full Text] [Related]
45. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
Rabban JT; Chen YY
Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495
[TBL] [Abstract][Full Text] [Related]
46. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
Rakha EA; Abd El Rehim D; Pinder SE; Lewis SA; Ellis IO
Histopathology; 2005 Jun; 46(6):685-93. PubMed ID: 15910600
[TBL] [Abstract][Full Text] [Related]
47. Analysis of the immunohistochemical expression of mammaglobin A in primary breast carcinoma and lymph node metastasis.
Raica M; Cîmpean AM; Meche A; Alexa A; Suciu C; Mureşan A
Rom J Morphol Embryol; 2009; 50(3):341-7. PubMed ID: 19690758
[TBL] [Abstract][Full Text] [Related]
48. [Flow cytometric quantitative analysis of multiple tumor suppressor gene 1 (MTS1) and cyclooxygenase-2 (COX-2) gene expressions in invasive breast cancers and their clinical significance].
Zuo WS; Wei L; Wang XW; Wang YS; Yu ZY; Bi Y; Liu YS; Zhou ZB
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):515-7. PubMed ID: 17147116
[TBL] [Abstract][Full Text] [Related]
49. Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival.
Tommiska J; Eerola H; Heinonen M; Salonen L; Kaare M; Tallila J; Ristimäki A; von Smitten K; Aittomäki K; Heikkilä P; Blomqvist C; Nevanlinna H
Clin Cancer Res; 2005 Jul; 11(14):5098-103. PubMed ID: 16033823
[TBL] [Abstract][Full Text] [Related]
50. Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.
Cheang MC; Treaba DO; Speers CH; Olivotto IA; Bajdik CD; Chia SK; Goldstein LC; Gelmon KA; Huntsman D; Gilks CB; Nielsen TO; Gown AM
J Clin Oncol; 2006 Dec; 24(36):5637-44. PubMed ID: 17116944
[TBL] [Abstract][Full Text] [Related]
51. Thrombospondin-1 expression as a prognostic predictor of pancreatic ductal carcinoma.
Tobita K; Kijima H; Dowaki S; Oida Y; Kashiwagi H; Ishii M; Sugio Y; Sekka T; Ohtani Y; Tanaka M; Inokuchi S; Makuuchi H
Int J Oncol; 2002 Dec; 21(6):1189-95. PubMed ID: 12429967
[TBL] [Abstract][Full Text] [Related]
52. Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinoma.
Acs G; Dumoff KL; Solin LJ; Pasha T; Xu X; Zhang PJ
Am J Surg Pathol; 2007 Jan; 31(1):129-40. PubMed ID: 17197929
[TBL] [Abstract][Full Text] [Related]
53. [Correlations of HER-2, PCNA, Bcl-2, and Bax expression to prognosis of breast cancer].
Yang L; Zhu X; Ran L
Ai Zheng; 2007 Jul; 26(7):756-61. PubMed ID: 17626754
[TBL] [Abstract][Full Text] [Related]
54. [Quantitative detection of telomerase activity and its association with clinicopathological characteristics in breast cancer].
He GP; Shui QL; Huang Y; Zhang SZ; Yu H
Ai Zheng; 2004 Sep; 23(9):1041-6. PubMed ID: 15363198
[TBL] [Abstract][Full Text] [Related]
55. [Expression of angiogenesis-related factors in invasive breast cancer and its clinical significance].
Wang XB; Yang QX; Pei XJ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):860-3. PubMed ID: 16793622
[TBL] [Abstract][Full Text] [Related]
56. Correlation of tissue inhibitor of metalloproteinase-2 with proliferative activity and patients' survival in breast cancer.
Nakopoulou L; Katsarou S; Giannopoulou I; Alexandrou P; Tsirmpa I; Panayotopoulou E; Mavrommatis J; Keramopoulos A
Mod Pathol; 2002 Jan; 15(1):26-34. PubMed ID: 11796838
[TBL] [Abstract][Full Text] [Related]
57. High level of Notch1 protein is associated with poor overall survival in colorectal cancer.
Chu D; Li Y; Wang W; Zhao Q; Li J; Lu Y; Li M; Dong G; Zhang H; Xie H; Ji G
Ann Surg Oncol; 2010 May; 17(5):1337-42. PubMed ID: 20058190
[TBL] [Abstract][Full Text] [Related]
58. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters.
Bolat F; Kayaselcuk F; Nursal TZ; Yagmurdur MC; Bal N; Demirhan B
J Exp Clin Cancer Res; 2006 Sep; 25(3):365-72. PubMed ID: 17167977
[TBL] [Abstract][Full Text] [Related]
59. [Relationship between tissue inhibitors of metalloproteinase and metastasis and prognosis in breast cancer].
Jiang X; Huang X; Li J; Shi Y; Zhou L
Zhonghua Wai Ke Za Zhi; 2000 Apr; 38(4):291-3, 19. PubMed ID: 12828172
[TBL] [Abstract][Full Text] [Related]
60. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
